title: [The status of gene therapy in cardiovascular medicine].
abstract: Vascular gene transfer potentially offers new treatments for cardiovascular diseases. It may be used to overexpress therapeutically important proteins and correct genetic defects, and to test experimentally the effects of various genes in a local vascular compartment. Vascular endothelial growth factor (VEGF) and fibroblast growth factor (FGF) gene transfers have improved blood flow and collateral development in ischemic limb and myocardium. Promising therapeutic effects have been obtained in animal models of restenosis or vein-graft thickening with the transfer of genes coding for VEGF, nitric-oxide synthase, thymidine kinase, retinoblastoma, growth arrest homoeobox, tissue inhibitor of metalloproteinases, cyclin or cyclin-dependent kinase inhibitors, fas ligand and hirudin, and antisense oligonucleotides against transcription factors or cell-cycle regulatory proteins. First experiences of VEGF gene transfer and decoy oligonucleotides in human beings have been reported. However, further developments in gene transfer vectors, gene delivery techniques and identification of effective treatment genes will be required before the full therapeutic potential of gene therapy in cardiovascular disease can be assessed.
authors.affiliation: II. Interne Abteilung mit Kardiologie und Internistische Intensivmedizin, Allgemeines öffentliches Krankenhaus der Barmherzigen Schwestern vom Hl. Kreuz, Wels, Osterreich. johann.auer@khwels.at
authors.forename: J
authors.initials: J
authors.lastname: Auer
authors.forename: R
authors.initials: R
authors.lastname: Berent
authors.forename: K
authors.initials: K
authors.lastname: Schleicher
authors.forename: B
authors.initials: B
authors.lastname: Eber
mesh_terms: D000818:Animals; D002318:Cardiovascular Diseases / Q000235:genetics / Q000628:therapy*; D016228:Endothelial Growth Factors / Q000235:genetics; D005346:Fibroblast Growth Factors / Q000235:genetics; D018014:Gene Transfer Techniques; D015316:Genetic Therapy; D006801:Humans; D008222:Lymphokines / Q000235:genetics; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
chemical_list: D016228:Endothelial Growth Factors; D008222:Lymphokines; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; D005346:Fibroblast Growth Factors